Anti-skin specific autoantibodies detected by a new immunofluorescence multiplex biochip method in patients with autoimmune bullous diseases

Dermatology

Volumn 225, Issue 1, 2012, Pages 37-44

  Tampoia, Marilina ^a   Zucano, Antonietta ^a   Villalta, Danilo ^b   Antico, Antonio ^c   Bizzaro, Nicola ^d  

^a POLICLINICO   (Italy)

^b S MARIA DEGLI ANGELI HOSPITAL   (Italy)

^c Ospedale Civile   (Italy)

^d Ospedale San Antonio   (Italy)

Author keywords

Autoimmune bullous diseases; Bullous pemphigoid; Bullous pemphigoid 180 kDa; Bullous pemphigoid 230 kDa; Desmoglein; Enzyme linked immunosorbent assay; Multiplex biochip method; Pemphigus vulgaris

Indexed keywords

AUTOANTIBODY; BULLOUS PEMPHIGOID ANTIGEN 1; DESMOGLEIN 1 ANTIBODY; DESMOGLEIN 3 ANTIBODY; PROTEIN BP 180; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ARTICLE; BIOCHIP; BLOOD SAMPLING; BULLOUS PEMPHIGOID; CONTROLLED STUDY; DIAGNOSTIC KIT; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGUS; GENETIC TRANSFECTION; HAPLORHINI; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; MAJOR CLINICAL STUDY; NONHUMAN; PEMPHIGUS VULGARIS; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

AUTOANTIBODIES; AUTOANTIGENS; CASE-CONTROL STUDIES; DESMOGLEIN 1; DESMOGLEIN 3; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MEMBRANE GLYCOPROTEINS; MICROARRAY ANALYSIS; NON-FIBRILLAR COLLAGENS; PEMPHIGOID, BULLOUS; PEMPHIGUS; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; SKIN;

EID: 84867744359     PISSN: 10188665     EISSN: 14219832     Source Type: Journal    
DOI: 10.1159/000339776     Document Type: Article

References (39)

1. Stanley JR: Pemphigus and pemphigoid as paradigm of organ-specific autoantibodies mediated diseases. J Clin Invest 1989; 83: 1443-1448. (Pubitemid 19124095)
2. Stanley JR: Cell adhesion molecules as targets of autoantibodies in pemphigus and pemphigoid, bullous diseases due to defective epidermal cell adhesion. Adv Immunol 1993; 53: 291-325.
3. Koch PJ, Walsh MJ, Schmelz M, Goldschmidt MZ, Zimbelmann R, Franke WW: Identification of desmoglein, a constitutive desmosomal glycoprotein, as a member of the cadherin family of cell adhesion molecules. Eur J Cell Biol 1990; 53: 1-12. (Pubitemid 20368179)
4. Eyre RW, Stanley JR: Identification of pemphigus vulgaris antigen extracted from normal human epidermis and comparison with pemphigus foliaceus antigen. J Clin Invest 1988; 81: 807-812. (Pubitemid 18079729)
5. Amagai M, Tsunoda K, Zillikens D, Nagai T, Nishikawa T: The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile. J Am Acad Dermatol 1999; 40: 167-170. (Pubitemid 29072792)
6. Ishii K, Amagai M, Hall RP, Hashimoto T, Nagai T, Nishikawa T: Characterization of autoantibodies in pemphigus using antigen specific enzyme linked immunosorbent assays with baculovirus-expressed recombinant desmogleins. J Immunol 1997; 159: 2010-2017. (Pubitemid 127484192)
7. Amagai M, Komai A, Hashimoto T, Shirakata Y, Hashimoto K, Yamada T, Kitajima Y, Ohya K, Iwanami H, Nishikawa T: Usefulness of enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3 for serodiagnosis of pemphigus. Br J Dermatol 1999; 140: 351-357. (Pubitemid 29111371)
8. Harman KE, Gratian MJ, Seed PT, Bhogal BS, Challacombe SJ, Black MM: Diagnosis of pemphigus by ELISA: A critical evaluation of two ELISAs for the detection of antibodies to the major pemphigus antigens, desmoglein 1 and 3. Clin Exp Dermatol 2000; 25: 236-240. (Pubitemid 30340557)
9. Harman KE, Seed PT, Gratian MJ, Bhogal BS, Challacombe SJ, Black MN: The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels. Br J Dermatol 2001; 144: 775-780. (Pubitemid 32374780)
10. Schmidt E, Dahnrich C, Rosemann A, Probst C, Komorowski L, Saschenbrecker S, Schlumberger W, Stöcker W, Hashimoto T, Bröcker EB, Recke A, Rose C, Zillikens D: Novel ELISA systems for antibodies to desmoglein 1 and 3: Correlation of disease activity with serum autoantibody levels in individual pemphigus patients. Exp Dermatol 2010; 19: 458-463.
11. Sharma PM, Choi RJ, Kuroda K, Hachiya T, Ishii K, Payne AS: Pathogenic anti-desmoglein MAbs show variable ELISA activity because of preferential binding of mature versus proprotein isoforms of desmoglein 3. J Invest Dermatol 2009; 129: 2309-2312.
12. Yokouchi M, Saleh MA, Kuroda K, Hachiva T, Stanley JR, Amagai M, Ishii K: Pathogenic epitopes of autoantibodies in pemphigus reside in the amino-terminal adhesive region of desmogleins which are unmasked by proteolytic processing of prosequence. J Invest Dermatol 2009; 129: 2156-2166.
13. Varshavsky A, Kessler O, Abramovitch S, Kigel B, Zaffryar S, Akiri G, Neufelg G: Semaphorin-3B is an angiogenesis inhibitor that is inactivated by furin-like pro-protein convertases. Cancer Res 2008; 17: 6922-6931.
14. Matsumura K, Amagai M, Nishikawa T, Hashimoto T: The majority of bullous pemphigoid and herpes gestationis serum samples react with the NC16a domain of the 180-kDa bullous pemphigoid antigen. Arch Dermatol Res 1996; 288: 507-509. (Pubitemid 26280698)
15. Kobayashi M, Amagai M, Kuroda-Kinoshita K, Hashimoto T, Shirakata Y, Hashimoto K, Nishikawa T: BP180 ELISA using bacterial recombinant NC16a protein as a diagnostic and monitoring tool for bullous pemphigoid. J Dermatol Sci 2002; 30: 224-232. (Pubitemid 35351315)
16. Di Zenzo G, Grosso F, Terracina M, Mariotti F, De Pità O, Owaribe K, Mastrogiacomo A, Sera F, Borradori L, Zambruno G: Characterization of the anti-BP180 autoantibody reactivity profile and epitope mapping in bullous pemphigoid patients. J Invest Dermatol 2004; 122: 103-110. (Pubitemid 38114646)
17. Thoma-Uszynski S, Uter W, Schwietzke S, Schuler G, Borradori L, Hertl M: Autoreactive T and B cells from bullous pemphigoid (BP) patients recognize epitopes clustered in distinct regions of BP180 and BP230. J Immunol 2006; 176: 2015-2023. (Pubitemid 43134347)
18. Sitaru C, Dahnrich C, Probst C, Komorowski L, Blocker I, Schmidt E, Saschenbrecker S, Rose C, Stocker W, Zillikens D: Enzymelinked immunosorbent assay using multimers of the 16th non-collagenous domain of the BP180 antigen for sensitive and specific detection of pemphigoid autoantibodies. Exp Dermatol 2007; 16: 770-777. (Pubitemid 47261869)
19. Skaria M, Jaunin F, Hunziker T, Riou S, Schumann H, Bruckner-Tuderman L, Hertl M, Bernard P, Saurat JH, Fabre B, Borradori L: IgG autoantibodies from bullous pemphigoid patients recognize multiple antigenic reactive sites located predominantly within the B and C subdomains of the COOH-terminus of BP230. J Invest Dermatol 2000; 114: 998-1004. (Pubitemid 30252723)
20. Kromminga A, Sitaru C, Hagel C, Herzog S, Zillikens D: Development of an ELISA for the detection of autoantibodies to BP230. Clin Immunol 2004; 111: 146-152. (Pubitemid 38482094)
21. Yoshida M, Hamada T, Amagai M, Hashimoto K, Uehara R, Yamaguchi K, Imamura K, Okamoto E, Yasumoto S, Hashimoto T: Enzyme-linked immunosorbent assay using bacterial recombinant proteins of human BP230 as a diagnostic tool for bullous pemphigoid. J Dermatol Sci 2006; 41: 21-30. (Pubitemid 43075429)
22. Tampoia M, Lattanzi V, Zucano A, Villalta D, Filotico R, Fontana A, Vena GA, Di Serio F: Evaluation of a new ELISA assay for detection of BP230 autoantibodies in bullous pemphigoid. Ann NY Acad Sci 2009; 1173: 15-20.
23. Marazza G, Pham HC, Schärer L, Pedrazzetti PP, Hunziker T, Trueb RM, Hohl D, Itin P, Lautenschlager S, Naldi L, Borradori L, Autoimmune Bullous Disease Swiss Study Group: Incidence of bullous pemphigoid and pemphigus in Switzerland: A 2-year prospective study. Br J Dermatol 2009; 161: 861- 868.
24. Blöcker IM, Dähnrich C, Probst C, Komorowski L, Saschenbrecker S, Schlumberger W, Stöcker W, Zillikens D, Schmidt E: Epitope mapping of BP230 leading to a novel enzyme-linked immunosorbent assay for autoantibodies in bullous pemphigoid. Br J Dermatol 2012; 166: 964-970.
25. Marinović B, Fabris Z, Lipozencić J, Stulhofer Buzina D, Lakos Jukić I: Comparison of diagnostic value of indirect immunofluorescence assay and desmoglein ELISA in the diagnosis of pemphigus. Acta Dermatovenereol Croat 2010; 18: 79-83.
26. Hamada T, Nagata Y, Tomita M, Salmhofer W, Hashimoto T: Bullous pemphigoid sera react specifically with various domains of BP230, most frequently with C-terminal domain, by immunoblot analyses using bacterial recombinant proteins covering the entire molecule. Exp Dermatol 2001; 10: 256- 263. (Pubitemid 32754994)
27. Feng S, Lin L, Jin P, Wu Q, Zhou W, Sang H, Shao C: Role of BP180 NC16a-enzymelinked immunosorbent assay (ELISA) in the diagnosis of bullous pemphigoid in China. Int J Dermatol 2008; 47: 24-28.
28. Roussel A, Benichou J, Randriamanantany ZA, Gilbert D, Drenovska K, Houivet E, Tron F, Joly P: Enzyme-linked immunosorbent assay for the combination of bullous pemphigoid antigens 1 and 2 in the diagnosis of bullous pemphigoid. Arch Dermatol 2011; 147: 293-298.
29. Charneux J, Lorin J, Vitry F, Antonicelli F, Reguiai Z, Barbe C, Tabary T, Grange F, Bernard P: Usefulness of BP230 and BP180-NC16a enzyme-linked immunosorbent assays in the initial diagnosis of bullous pemphigoid: A retrospective study of 138 patients. Arch Dermatol 2011; 147: 286-291.
30. Lee EH, Kim YH, Kim S, Kim SE, Kim SC: Usefulness of enzyme-linked immunosorbent assay using recombinant BP180 and BP230 for serodiagnosis and monitoring disease activity of bullous pemphigoid. Ann Dermatol 2012; 24: 45-55.
31. Cohen J: A coefficient of agreement for nominal scales. Educ Psychol Meas 1960; 20: 37- 46.
32. Di Zenzo G, Thoma-Uszynski S, Fontao L, Calabresi V, Hofmann SC, Hellmark T, Sebbag N, Pedicelli C, Sera F, Lacour JP, Wieslander J, Bruckner-Tuderman L, Borradori L, Zambruno G, Hertl M: Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid. Clin Immunol 2008; 128: 415-426.
33. Di Zenzo G, Thoma-Uszynski S, Calabresi V, Fontao L, Hofmann SC, Lacour JP, Sera F, Bruckner-Tuderman L, Zambruno G, Borradori L, Hertl M: Demonstration of epitopespreading phenomena in bullous pemphigoid: Results of a prospective multicenter study. J Invest Dermatol 2011; 131: 2271- 2280.
34. Belloni-Fortina A, Faggion D, Pigozzi B, Peserico A, Bordignon M, Baldo V, Alaibac M: Detection of autoantibodies against recombinant desmoglein 1 and 3 molecules in patients with pemphigus vulgaris: Correlation with disease extent at the time of diagnosis and during follow-up. Clin Dev Immunol 2009; 2009: 187864.
35. Abasq C, Mouquet H, Gilbert D, Tron F, Grassi V, Musette P, Joly P: ELISA testing of anti-desmoglein 1 and 3 antibodies in the management of pemphigus. Arch Dermatol 2009;145: 529-535.
36. Kwon EJ, Yamagami J, Nishikawa T, Amagai M: Anti-desmoglein IgG autoantibodies in patients with pemphigus in remission. J Eur Acad Dermatol Venereol 2008; 22: 1070- 1075.
37. Payne AS, Ishii K, Kacir S, Lin C, Li H, Hanakawa Y, Tsunoda K, Amagai M, Stanley JR, Siegel DL: Genetic and functional characterization of human pemphigus vulgaris monoclonal autoantibodies isolated by phage display. J Clin Invest 2005; 115: 888- 899. (Pubitemid 40489393)
38. Bernard P, Reguiai Z, Tancrède-Bohin E, Cordel N, Plantin P, Pauwels C, Vaillant L, Grange F, Richard-Lallemand MA, Sassolas B, Roujeau JC, Lok C, Picard-Dahan C, Chosidow O, Vitry F, Joly P: Risk factors for relapse in patients with bullous pemphigoid in clinical remission: A multicenter, prospective, cohort study. Arch Dermatol 2009; 145: 537-542.
39. Le Saché-de Peufeilhoux L, Ingen-Housz-Oro S, Hue S, Sbidian E, Valeyrie-Allanore L, Ortonne N, Roujeau JC, Wolkenstein P, Chosidow O, André C: The value of BP230 enzyme-linked immunosorbent assay in the diagnosis and immunological follow-up of bullous pemphigoid. Dermatology 2012; 224: 154-159.